- Home
- VNDA vs ELVR Comparison
VNDA vs ELVR Comparison
Compare VNDA & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- ELVR
- Stock Information
- Founded
- VNDA 2002
- ELVR 2000
- Country
- VNDA United States
- ELVR Australia
- Employees
- VNDA N/A
- ELVR N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- ELVR Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- VNDA Health Care
- ELVR Industrials
- Exchange
- VNDA Nasdaq
- ELVR Nasdaq
- Market Cap
- VNDA 249.4M
- ELVR 254.1M
- IPO Year
- VNDA 2006
- ELVR N/A
- Fundamental
- Price
- VNDA $4.41
- ELVR $25.54
- Analyst Decision
- VNDA Strong Buy
- ELVR
- Analyst Count
- VNDA 3
- ELVR 0
- Target Price
- VNDA $14.00
- ELVR N/A
- AVG Volume (30 Days)
- VNDA 682.0K
- ELVR 107.2K
- Earning Date
- VNDA 10-29-2025
- ELVR 10-29-2025
- Dividend Yield
- VNDA N/A
- ELVR N/A
- EPS Growth
- VNDA N/A
- ELVR N/A
- EPS
- VNDA N/A
- ELVR N/A
- Revenue
- VNDA $212,074,000.00
- ELVR $146,440,045.00
- Revenue This Year
- VNDA $14.32
- ELVR $9.75
- Revenue Next Year
- VNDA $37.05
- ELVR $8.82
- P/E Ratio
- VNDA N/A
- ELVR N/A
- Revenue Growth
- VNDA 11.12
- ELVR 11.20
- 52 Week Low
- VNDA $3.81
- ELVR $15.55
- 52 Week High
- VNDA $5.70
- ELVR $33.36
- Technical
- Relative Strength Index (RSI)
- VNDA 34.91
- ELVR N/A
- Support Level
- VNDA $4.32
- ELVR N/A
- Resistance Level
- VNDA $4.51
- ELVR N/A
- Average True Range (ATR)
- VNDA 0.23
- ELVR 0.00
- MACD
- VNDA -0.13
- ELVR 0.00
- Stochastic Oscillator
- VNDA 9.44
- ELVR 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.